Search

Your search keyword '"Selvaggio, Oscar"' showing total 181 results

Search Constraints

Start Over You searched for: Author "Selvaggio, Oscar" Remove constraint Author: "Selvaggio, Oscar"
181 results on '"Selvaggio, Oscar"'

Search Results

2. MP74-11 COMPARISON OF PCA DETECTION RATES IN PATIENTS WHO UNDERWENT MRI/TRUS FUSION PROSTATE BIOPSY: ELASTIC VS RIGID SOFTWARE-BASED SYSTEMS

3. Combined Use of Prostate-specific Antigen Density and Magnetic Resonance Imaging for Prostate Biopsy Decision Planning: A Retrospective Multi-institutional Study Using the Prostate Magnetic Resonance Imaging Outcome Database (PROMOD)

5. External Validation of the IMPROD-MRI Volumetric Model to Predict the Utility of Systematic Biopsies at the Time of Targeted Biopsy

6. Abiraterone Acetate for Treatment of Metastatic Castration-resistant Prostate Cancer in Chemotherapy-naive Patients: An Italian Analysis of Patients' Satisfaction

9. Foggia Prostate Cancer Risk Calculator 2.0: A Novel Risk Calculator including MRI and Bladder Outlet Obstruction Parameters to Reduce Unnecessary Biopsies

10. Oncological outcomes of whole-gland cryoablation in patients with prostate cancer and high risk of lymph node invasion

11. Pros-IT CNR: an Italian prostate cancer monitoring project

15. One-Day Prostate Cancer Diagnosis: Biparametric Magnetic Resonance Imaging and Digital Pathology by Fluorescence Confocal Microscopy

17. Oncological outcomes of whole-gland cryoablation in patients with prostate cancer and high risk of lymph node invasion.

18. MP46-14 INTRAOPERATIVE DIGITAL ANALYSIS OF ABLATION MARGINS (DAAM) BY FLUORESCENT CONFOCAL MICROSCOPY TO IMPROVE THE ACCURACY OF PARTIAL PROSTATE GLAND CRYOABLATION: A PILOT STUDY

19. Intraoperative Digital Analysis of Ablation Margins (DAAM) by Fluorescent Confocal Microscopy to Improve Partial Prostate Gland Cryoablation Outcomes

20. PSA Density Help to Identify Patients With Elevated PSA Due to Prostate Cancer Rather Than Intraprostatic Inflammation: A Prospective Single Center Study

21. Prospective Validation of Pentraxin-3 as a Novel Serum Biomarker to Predict the Risk of Prostate Cancer in Patients Scheduled for Prostate Biopsy

22. Does Multiparametric Magnetic Resonance of Prostate Outperform Risk Calculators in Predicting Prostate Cancer in Biopsy Naïve Patients?

28. Bioptic prostatic inflammation correlates with false positive rates of multiparametric magnetic resonance imaging in detecting clinically significant prostate cancer.

33. Additional file 1: of Safety and efficacy of abiraterone acetate in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: an Italian multicenter â real lifeâ study

35. Development and Internal Validation of Novel Nomograms Based on Benign Prostatic Obstruction-Related Parameters to Predict the Risk of Prostate Cancer at First Prostate Biopsy

36. Safety and efficacy of abiraterone acetate in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: an Italian multicenter “real life” study

37. Pros-IT CNR: an Italian prostate cancer monitoring project

39. Human Epidermal Growth Factor Receptor 2 in Non-Muscle Invasive Bladder Cancer: Issues in Assessment Methods and Its Role as Prognostic/Predictive Marker and Putative Therapeutic Target: A Comprehensive Review.

40. Morphological and Immunohistochemical Biomarkers in Distinguishing Prostate Carcinoma and Urothelial Carcinoma: A Comprehensive Review.

41. Prognostic and therapeutic role of HER2 expression in micropapillary carcinoma of the bladder.

42. Prognostic Factors for Anastomotic Urinary Leakage Following Retropubic Radical Prostatectomy and Correlation With Voiding Outcomes

45. Pentraxin 3: A Novel Biomarker for Predicting Progression from Prostatic Inflammation to Prostate Cancer

Catalog

Books, media, physical & digital resources